AGX101 is an antibody-drug conjugate (ADC) therapy for tumor-forming cancers. The purpose of this study is to learn about AGX101 effects and safety at various …

CancerAdvanced CancerLocally Advanced Carcinoma+8 more

~Estimated

~$10 – $8,750

Angiex, Inc.NCT06440005

Phase 2

A Phase 2 Study of Lattice Radiotherapy for Dose-Escalated Palliation of Bulky Tumors

The purpose of this research study is to determine if lattice radiation therapy (LRT) will provide better treatment for bulky (large) tumors than current stand…

CancerMetastatic CancerLocally Advanced+2 more

~Estimated

~$10 – $5,625

University of CincinnatiNCT06416007